Search results
Results From The WOW.Com Content Network
Schedule H is a class of prescription drugs in India appearing as an appendix to the Drugs and Cosmetics Rules, 1945 introduced in 1945. These are drugs which cannot be purchased over the counter without the prescription of a qualified doctor. The manufacture and sales of all drugs are covered under the Drugs and Cosmetics Act and Rules.
This method of citation is in theory compulsory worldwide for substances in Schedule I of the Single Convention on Narcotic Drugs 1961, a classification corresponding to opioids in US Schedule II with Narcotic classification plus cocaine (which inherited a narcotic designation from the 1931 Convention for Limiting the Manufacture and Regulating ...
The Schedule J of the Drugs and Cosmetics Rules, 1945 of India contains "a list of diseases and ailments which a drug may not claim to prevent or cure". Under Rule 106 of the Drugs and Cosmetics Act, 1940, a drug cannot make claims to treat or prevent any of the diseases or reform the conditions listed.
Schedule X is a class of prescription drugs in India appearing as an appendix to the Drugs and Cosmetics Rules introduced in 1945. These are drugs which cannot be purchased over the counter without a valid prescription of a Registered Medical Practitioner (RMP). Also, the retailer has to preserve the prescription for a period of two years. [1]
Dimethylpentylone is not specifically listed in the United States Controlled Substance Act but would be considered Schedule I as a positional isomer of the Schedule I substance N-Ethylpentylone in the United States, defined as "all isomers" within that definition. [9] [10]
The legislation classifies these drugs into five schedules, with varying qualifications for each schedule. The schedules are designated schedule I, schedule II, schedule III, schedule IV, and schedule V. Many drugs other than controlled substances require a prescription.
Despite this, DEA administrator John C. Lawn overruled and classified the drug as Schedule I. [151] [178] Harvard psychiatrist Lester Grinspoon then sued the DEA, claiming that the DEA had ignored the medical uses of MDMA, and the federal court sided with Grinspoon, calling Lawn's argument "strained" and "unpersuasive", and vacated MDMA's ...
The removal of cannabis and cannabis resin from Schedule IV of the Single Convention on narcotic drugs, 1961 is a change in international law that took place in 2021, on the basis of a scientific assessment by the World Health Organization.